Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Joint Committee on Vaccination and Immunisation's report entitled Respiratory syncytial virus (RSV) immunisation programme for adults aged 80 years and older: JCVI advice, published on 16 July 2025, whether the NHS is offering the respiratory syncytial virus vaccine to (a) all adults aged 80 years old and over and (b) all residents of adult care homes.

In advice published on 16 July 2025, the Joint Committee on Vaccination and Immunisation (JCVI) advised that the routine respiratory syncytial virus (RSV) programme be extended to also include adults aged 80 years and older, and all residents in a care home for older adults.

During a debate on Accident and Emergency Waiting Times on 22 July 2025, my Rt. Hon. Friend, the Secretary of State for Health and Social Care, confirmed to the Hon. Member that we had already accepted the JCVI advice to extend the routine RSV programme and reassured you that the Department was working at pace on implementation. He did not confirm plans or timings to implement the advice.

At Oral Answers to Questions – Health and Social Care, on 21 October 2025, my Rt. Hon. Friend told the Hon. Member that we had delivered on the commitment to extend the routine RSV programme to adults aged 80 years and older, and all residents in a care home for older adults. His response referred to the acceptance of the JCVI advice and ongoing work to implement that advice. The RSV programme could not be expanded ahead of this winter. However, we have updated the eligibility of the catch-up programme for 7579-year-olds so anyone who turned 80 on or after 1 September 2024 but has not yet come forward for vaccination can continue to do so. Initially, those who turned 80 in the first year of the programme only remained eligible until 31 August 2025, but that has now been extended.

The Department is in discussions with NHS England and the UK Health Security Agency on potential implementation. The Department is exploring delivery options and their impact, including on other vaccination programmes, to ensure any changes deliver the best value for money. We will make a final decision about whether and how to implement the JCVI’s advice, including the timing of any expansion to the older adult RSV programme, when this work has concluded.